What is HSBC's price target for LH?

HSBC's latest stated price target for Labcorp Holdings Inc. (LH) is $410, from its action on Nov 5, 2026.

What is HSBC's rating on LH?

HSBC rates LH Buy, a bullish rating, as of Nov 5, 2026.

When did HSBC last change its view on LH?

On Nov 5, 2026, HSBC upgrades to Buy from Hold, price target $410.

HSBC LH price target and rating history

Labcorp Holdings Inc. (LH) · Health Care

HSBC rates Labcorp Holdings Inc. (LH) Buy with a $410 price target, as of its latest action on Nov 5, 2026. It has published 4 rating actions on LH since September 2023, including 2 upgrades and 1 downgrade.

Current rating: Buy
Price target: $410
Median target, all firms: Too few
Actions on LH: 4

HSBC price target on LH

HSBC price target on LH, each point a stated target, September 2023 to November 2026.

Every HSBC rating on LH

Nov 5, 2026
UpgradeHSBC upgrades to Buy from Hold, price target $410
Jul 10, 2025
DowngradeHSBC downgrades to Hold from Buy, price target $260
Oct 30, 2024
UpgradeHSBC upgrades to Buy from Hold
Sep 6, 2023
InitiateHSBC starts coverage at Hold, price target $210

Questions about HSBC and LH

What is HSBC's price target for LH?: HSBC's latest stated price target for Labcorp Holdings Inc. (LH) is $410, from its action on Nov 5, 2026.
What is HSBC's rating on LH?: HSBC rates LH Buy, a bullish rating, as of Nov 5, 2026.
When did HSBC last change its view on LH?: On Nov 5, 2026, HSBC upgrades to Buy from Hold, price target $410.

More LH rating histories

All HSBC ratings LH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.